Alvotech (ALVO) Intangibles (2020 - 2026)
Alvotech (ALVO) posted Intangibles of $119.6 million for Q1 2026, up 46.14% on a QoQ basis from $81.8 million in Q4 2025, and up 455.24% year-over-year from $21.5 million in Q1 2025.
Alvotech (ALVO) Intangibles (2020 - 2026) Analysis & Trends
Alvotech's Intangibles history runs 7 years deep, the most recent figure standing at $119.6 million for Q1 2026.
- Quarterly Intangibles rose 455.24% year-over-year to $119.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.6 million (up 455.24% YoY) and the FY2025 annual result came in at $81.8 million, up 296.85% from the prior year.
- Intangibles was $119.6 million for Q1 2026 at Alvotech, up from $81.8 million in the prior quarter.
- Across five years, Intangibles topped out at $119.6 million in Q1 2026 and bottomed at $3.3 million in Q4 2022.
- A 5-year average of $34.4 million and a median of $20.6 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles plunged 38.72% — and 2026, when it soared 455.24%.
- Alvotech's Intangibles stood at $3.3 million in 2022, then soared by 87.5% to $6.3 million in 2023, then soared by 228.99% to $20.6 million in 2024, then jumped by 296.85% to $81.8 million in 2025, then jumped by 46.14% to $119.6 million in 2026.
- Business Quant data shows ALVO's Intangibles at $119.6 million in Q1 2026, $81.8 million in Q4 2025, and $61.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 119.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.59 Mn |
| Dec 31, 2025 | 81.83 Mn |
| Sep 30, 2025 | 61.87 Mn |
| Jun 30, 2025 | 54.69 Mn |
| Mar 31, 2025 | 21.54 Mn |
| Dec 31, 2024 | 20.62 Mn |
| Sep 30, 2024 | 20.54 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 19.37 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Jun 30, 2023 | 14.01 Mn |
| Mar 31, 2023 | 14.53 Mn |
| Dec 31, 2022 | 3.34 Mn |
| Jun 30, 2022 | 22.86 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Dec 31, 2020 | 10.13 Mn |